The study will compare durations of diarrhea among subjects who report to clinic for treatment and who receive either: 1. standard rifaximin therapy at a dose of 200 mg three times a day for 3 days, OR 2. a single 600 mg dose of rifaximin daily for 3 days.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Rifaximin 200 mg TID for 3 days OR Rifaximin 600 mg Daily for 3 days
Enteric Disease Clinic
Guadalajara, Jalisco, Mexico
Time from beginning therapy to passage of last unformed stool
Time frame: 5 days
Side effects as reported by the subjects on diaries
Time frame: 5 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.